Subtopic Deep Dive
PVAT Regulation of Vascular Function
Research Guide
What is PVAT Regulation of Vascular Function?
PVAT (perivascular adipose tissue) regulation of vascular function refers to the paracrine control exerted by adipocytes surrounding blood vessels on endothelial-dependent relaxation and vasoconstriction through adipokines, inflammatory mediators, and gases like hydrogen sulfide.
PVAT normally provides anticontractile effects on vasculature, but obesity-induced inflammation and hypoxia abolish this protection (Greenstein et al., 2009, 611 citations). Epicardial and perivascular fat depots secrete proinflammatory cytokines that impair vascular homeostasis (Mazurek et al., 2003, 1921 citations). Over 20 key papers since 2003 document PVAT's shift from protective to maladaptive in cardiometabolic disease.
Why It Matters
PVAT dysfunction links local adiposity to endothelial impairment in hypertension and atherosclerosis, as shown in ex vivo artery models where inflamed PVAT enhances vasoconstriction (Greenstein et al., 2009). This explains obesity's role in HFpEF phenotypes independent of systemic factors (Obokata et al., 2017). Targeting PVAT mediators like those identified by Mazurek et al. (2003) offers therapies to restore vascular protection, impacting 40% of cardiovascular disease cases tied to visceral fat (Mahabadi et al., 2008).
Key Research Challenges
Obesity-Induced PVAT Inflammation
Obesity triggers hypoxia and cytokine release in PVAT, abolishing anticontractile effects on arteries (Greenstein et al., 2009). This shifts PVAT to proinflammatory phenotype promoting endothelial dysfunction (Chatterjee et al., 2009). Dissecting depot-specific mechanisms remains difficult without advanced imaging.
PVAT-Vasculature Crosstalk Mechanisms
Paracrine factors from PVAT like adipokines modulate vascular tone, but identification of key mediators is incomplete (Koenen et al., 2021). Ex vivo models reveal loss of H2S-mediated relaxation in obese PVAT (Greenstein et al., 2009). Translating these to in vivo human disease is challenging.
Therapeutic Targeting of PVAT
Inhibiting PVAT fibrosis and angiogenesis deficits could restore vascular function, but specificity is low (Crewe et al., 2017). Clinical trials lack PVAT-focused endpoints despite associations with CVD burden (Mahabadi et al., 2008). Depot-selective interventions need validation.
Essential Papers
Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators
Tomasz Mazurek, Lifeng Zhang, Andrew Zalewski et al. · 2003 · Circulation · 1.9K citations
Background— Inflammatory mediators that originate in vascular and extravascular tissues promote coronary lesion formation. Adipose tissue may function as an endocrine organ that contributes to an i...
Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
Alan Chait, Laura J. den Hartigh · 2020 · Frontiers in Cardiovascular Medicine · 1.4K citations
Adipose tissue plays essential roles in maintaining lipid and glucose homeostasis. To date several types of adipose tissue have been identified, namely white, brown, and beige, that reside in vario...
Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction
Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru et al. · 2017 · Circulation · 1.1K citations
Background: Heart failure (HF) with preserved ejection fraction (HFpEF) is a heterogeneous syndrome. Phenotyping patients into pathophysiologically homogeneous groups may enable better targeting of...
Obesity, Adipose Tissue and Vascular Dysfunction
Mascha Koenen, Michael A. Hill, Paul Cohen et al. · 2021 · Circulation Research · 730 citations
Cardiovascular diseases are the leading cause of death worldwide. Overweight and obesity are strongly associated with comorbidities such as hypertension and insulin resistance, which collectively c...
The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis
Clair Crewe, Yu An, Philipp E. Scherer · 2017 · Journal of Clinical Investigation · 693 citations
There are three dominant contributors to the pathogenesis of dysfunctional adipose tissue (AT) in obesity: unresolved inflammation, inappropriate extracellular matrix (ECM) remodeling and insuffici...
Epicardial adipose tissue in contemporary cardiology
Gianluca Iacobellis · 2022 · Nature Reviews Cardiology · 654 citations
Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study
Amir A. Mahabadi, Joseph M. Massaro, Guido Aranha Rosito et al. · 2008 · European Heart Journal · 647 citations
Pericardial fat and VAT, but not intrathoracic fat, are associated with CVD independent of traditional measures of obesity but not after further adjustment for traditional risk factor. Taken togeth...
Reading Guide
Foundational Papers
Start with Mazurek et al. (2003, 1921 citations) for epicardial PVAT cytokines as CVD trigger; Greenstein et al. (2009, 611 citations) for obesity's abolition of anticontractile effects in human arteries; Mahabadi et al. (2008, 647 citations) for pericardial fat-CVD associations.
Recent Advances
Koenen et al. (2021, 730 citations) on obesity-adipose-vascular links; Iacobellis (2022, 654 citations) reviews epicardial PVAT cardiology; Chait & den Hartigh (2020, 1390 citations) on adipose distribution impacts.
Core Methods
Ex vivo isometric tension myography on PVAT-intact vessels; ELISA/IHC for adipokines (Greenstein 2009); MRI/CT volumetrics for PVAT quantification (Mahabadi 2008); hypoxia markers in obese adipose (Chatterjee 2009).
How PapersFlow Helps You Research PVAT Regulation of Vascular Function
Discover & Search
Research Agent uses searchPapers and citationGraph to map PVAT literature from Mazurek et al. (2003, 1921 citations) to recent works like Koenen et al. (2021), revealing 600+ connected papers on PVAT inflammation. exaSearch uncovers niche ex vivo studies on H2S signaling, while findSimilarPapers expands from Greenstein et al. (2009) to hypoxia mechanisms.
Analyze & Verify
Analysis Agent applies readPaperContent to extract cytokine profiles from Mazurek et al. (2003), then verifyResponse with CoVe checks claims against Greenstein et al. (2009). runPythonAnalysis processes citation networks or adipokine concentration data from abstracts via pandas for statistical trends. GRADE grading scores evidence strength for PVAT's anticontractile role.
Synthesize & Write
Synthesis Agent detects gaps like missing PVAT H2S interventions post-Greenstein (2009), flagging contradictions between protective (pre-obesity) and maladaptive PVAT states. Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing 20+ papers, latexCompile for publication-ready PDFs, and exportMermaid for PVAT-vasculature signaling diagrams.
Use Cases
"Extract adipokine concentration data from PVAT papers and plot obesity effects"
Research Agent → searchPapers('PVAT adipokines obesity') → Analysis Agent → readPaperContent(Greenstein 2009) + runPythonAnalysis(pandas plot cytokine levels vs vascular tone) → matplotlib figure of dose-response curves.
"Write LaTeX review on PVAT anticontractile loss in HFpEF"
Synthesis Agent → gap detection (Obokata 2017 + Koenen 2021) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(15 papers) → latexCompile → PDF with embedded PVAT inflammation diagram.
"Find code for PVAT ex vivo vessel analysis models"
Research Agent → paperExtractUrls(recent PVAT biomechanics papers) → Code Discovery → paperFindGithubRepo → githubRepoInspect → runnable Python scripts for finite element modeling of adipocyte-vascular crosstalk.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ PVAT papers: searchPapers → citationGraph(Mazurek 2003 hub) → GRADE all claims → structured report on inflammation progression. DeepScan's 7-step chain verifies hypoxia claims in Greenstein (2009) with CoVe checkpoints and runPythonAnalysis on metadata. Theorizer generates hypotheses on PVAT H2S restoration from Koenen (2021) patterns.
Frequently Asked Questions
What defines PVAT regulation of vascular function?
PVAT exerts paracrine control on vessel tone via adipokines and H2S, shifting from anticontractile protection to proinflammatory effects in obesity (Greenstein et al., 2009).
What methods study PVAT-vasculature interactions?
Ex vivo artery models with/without PVAT assess contraction to norepinephrine; immunohistochemistry detects cytokines (Mazurek et al., 2003; Greenstein et al., 2009).
What are key papers on PVAT in CVD?
Mazurek et al. (2003, 1921 citations) shows epicardial fat cytokines; Greenstein et al. (2009, 611 citations) proves obesity abolishes PVAT protection; Koenen et al. (2021) links to vascular dysfunction.
What open problems exist in PVAT research?
Depot-specific therapies targeting PVAT fibrosis (Crewe et al., 2017); in vivo validation of ex vivo H2S effects; integration with HFpEF phenotypes (Obokata et al., 2017).
Research Cardiovascular Disease and Adiposity with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching PVAT Regulation of Vascular Function with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers